Glaxo Wellcome Inc

Research Triangle Park, North Carolina 277093398

0 studies enrolling now · 17 studies all time

What they study most

AIDS Dementia Complex, HIV Infections, Neuromuscular Diseases, Pneumonia, Pneumocystis Carinii, Psoriasis

Studies at this site

• A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children. — Completed
• A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus — Completed
• A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease — Completed
• An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2 — Completed
• A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases — Completed
• A Prospective Double-Blind Study of Retrovir in Early HIV Infection — Completed
• A Study of 1592U89 in HIV-Infected Children — Completed
• A Study of 1592U89 in HIV-Infected Adults — Completed
• An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen — Completed
• A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS — Completed
• A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients — Completed
• A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus — Completed
• The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System — Completed
• A Study of Amprenavir in HIV-Infected Patients — Completed
• A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications — Completed
• An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine — Completed
• A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia — Completed